Clinical trial
Paclitaxel in Treating Women With Recurrent Solid Tumors
NCT00003130 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003130 |
|---|---|
| Title | Paclitaxel in Treating Women With Recurrent Solid Tumors |
| Official title | Prospective Evaluation of Body Surface Area (BSA) as a Determinant of Paclitaxel Pharmacokinetics/Pharmacodynamics in Women With Solid Tumors |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | paclitaxel |
| Enrollment | 32 |
| Start date | Nov 1, 1997 |
| Primary completion | Jan 1, 2002 |
| Completion | Jan 1, 2006 |
| First posted | Nov 25, 2003 |
| Last update posted | Jul 19, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: